Topical travoprost + Tobramycin + Dexamethasone
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Open-angle Glaucoma
Conditions
Open-angle Glaucoma
Trial Timeline
Mar 1, 2013 → Nov 8, 2019
NCT ID
NCT02873806About Topical travoprost + Tobramycin + Dexamethasone
Topical travoprost + Tobramycin + Dexamethasone is a approved stage product being developed by Glaukos for Open-angle Glaucoma. The current trial status is completed. This product is registered under clinical trial identifier NCT02873806. Target conditions include Open-angle Glaucoma.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02873806 | Approved | Completed |
Competing Products
20 competing products in Open-angle Glaucoma